Cargando…
From Bench to Market: Preparing Human Pluripotent Stem Cells Derived Cardiomyocytes for Various Applications
Human cardiomyocytes (CMs) cease to proliferate and remain terminally differentiated thereafter, when humans reach the mid-20s. Thus, any damages sustained by myocardium tissue are irreversible, and they require medical interventions to regain functionality. To date, new surgical procedures and drug...
Autores principales: | Moon, Sung-Hwan, Bae, Daekyeong, Jung, Taek-Hee, Chung, Eun-Bin, Jeong, Young-Hoon, Park, Soon-Jung, Chung, Hyung-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Stem Cell Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488771/ https://www.ncbi.nlm.nih.gov/pubmed/28531912 http://dx.doi.org/10.15283/ijsc17024 |
Ejemplares similares
-
Development of a Xeno-Free Autologous Culture System for Endothelial Progenitor Cells Derived from Human Umbilical Cord Blood
por: Moon, Sung-Hwan, et al.
Publicado: (2013) -
Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes
por: Choi, Seong Woo, et al.
Publicado: (2020) -
Transcriptome comparison between pluripotent and non-pluripotent calli derived from mature rice seeds
por: Shim, Sangrea, et al.
Publicado: (2020) -
Effect of Cell Labeling on the Function of Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Choi, Seong Woo, et al.
Publicado: (2020) -
Pharmaceutical nanotechnology: from the bench to the market
por: Mazayen, Zaed M., et al.
Publicado: (2022)